Today: 14 June 2026
IREN stock price rises in after-hours trade as focus shifts to Feb. 5 results
29 January 2026
1 min read

IREN stock price rises in after-hours trade as focus shifts to Feb. 5 results

New York, Jan 28, 2026, 19:14 EST — After-hours

  • IREN shares rose roughly 5% in after-hours trading following a volatile session
  • Investors are eyeing the Feb. 5 results for updates on AI data centers and mining operations
  • Bitcoin hovered around $89,000, while crypto-linked stocks showed a mixed bag.

IREN Limited shares jumped 4.9% in after-hours trading Wednesday, closing at $62.94. During the session, the stock fluctuated between $59.76 and $63.59.

This shift is significant since IREN now acts as a high-beta stand-in for two volatile plays: crypto-linked miners and energy-intensive AI computing. When the market jitters, the stock tends to move swiftly in step.

Now that the regular session is over, all eyes shift to the company’s upcoming trigger: the Q2 FY26 results call set for Feb. 5. Investors want new insights on capacity expansion and the pace at which contracted demand will translate into revenue.

Bitcoin hovered around $88,998, showing little movement. Among U.S.-listed miners and crypto-linked stocks, the action was mixed: Marathon Digital dropped 1.5%, Riot Platforms held steady, and CleanSpark gained 1.3% in recent trading.

IREN positions itself as a data-center operator focused on high-performance computing, boasting sites across North America that run entirely on renewable energy.

Momentum-style screens tracking price and earnings trends have also boosted sentiment. Investor’s Business Daily noted on Wednesday that IREN’s composite rating climbed, pointing to its revenue growth and signs of institutional buying.

Yet the stock could flip just as fast. A steep bitcoin slide, a pullback in AI-related shares, or a letdown on costs and schedules might erase Wednesday’s late gains.

Traders will be watching Thursday’s session closely to see if the after-hours bid holds up as liquidity comes back, and whether positions start to build ahead of the Feb. 5 report.

Stock Market Today

  • Indivior's Chief Scientific Officer Sells Shares Amid Stock Rally: Investor Implications
    June 14, 2026, 12:02 AM EDT. Christian Heidbreder, Chief Scientific Officer at Indivior Pharmaceuticals, sold 18,586 shares valued at $707,383 on June 11, 2026, representing 7.54% of his holdings. Post-sale, he retains 227,923 shares worth about $8.69 million, maintaining a 0.18% stake. The sale occurred during a significant stock price surge, with Indivior shares rising 177% over the past year, reflecting strong market performance amid growth in opioid dependence therapies. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, not signaling insider concerns. Indivior's strategy focuses on buprenorphine-based addiction treatments, with $1.29 billion in trailing twelve-month revenue and $252 million net income, underscoring its established market position and ongoing research-led expansion.

Latest articles

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

14 June 2026
Kraft Heinz closed up 0.70% at $24.39, outpacing the S&P 500, as investors weighed its 6.6% dividend yield against falling organic sales, lower adjusted earnings, and cautious analyst targets; the next earnings update is seen as the key test for whether $600 million in marketing and R&D can revive growth and support the stock’s rebound.
Gold price today: Bullion pushes toward $5,400 as Fed decision fails to cool the rally
Previous Story

Gold price today: Bullion pushes toward $5,400 as Fed decision fails to cool the rally

Oklo stock jumps nearly 11% on new Buy coverage as nuclear trade wakes up again
Next Story

Oklo stock jumps nearly 11% on new Buy coverage as nuclear trade wakes up again

Go toTop